Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 47.7027.698.479.606.50

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 47.70 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202447.70
Mar202327.69
Mar20228.47
Mar20219.60
Mar20206.50

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47
-11.77
Mar2021 9.6
47.69
Mar2020 6.5 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹39,976.5 Cr -1.7% -4.2% 37.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -7.3% 1.1% 15.2% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -3.5% 12.9% 53.4% Stock Analytics
CIPLA ₹122,717.0 Cr 0.1% 9.2% 6.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1% 0.2% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 3.1% 9.8% -7.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.7%

-4.2%

37.3%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses